Disposable ENDS Product Enforcement Act of 2023
Latest action · Feb 17, 2023 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 9, 2023
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Disposable ENDS Product Enforcement Act of 2023
This bill requires the Food and Drug Administration (FDA) to update its enforcement guidance regarding Electronic Nicotine Delivery System (ENDS) products to include certain disposable ENDS products.
In April 2020, the FDA published revised guidance on how it intends to prioritize enforcement resources with respect to ENDS products that do not have premarket authorization (i.e., that have not received FDA approval). The guidance specifies that the FDA intends to prioritize enforcement against (1) flavored, cartridge-based ENDS products (except for tobacco or menthol flavored products); (2) other ENDS products for which the manufacturer has not taken adequate measures to prevent access to minors; (3) any ENDS products that are targeted or promoted towards minors; and (4) any ENDS products for which the manufacturer has not submitted an application for market approval or did not receive approval.
For purposes of this guidance, cartridge-based ENDS products do not include disposable products that are completely self-contained. The bill requires the FDA to incorporate these products, including nicotine products that are not derived from tobacco, into its enforcement priorities. The bill additionally specifies that the FDA may prioritize enforcement against these products in advance of updating the guidance. The FDA must also annually report on its enforcement actions with respect to these products.
Cosponsors 21
Members who signed on, in the order they did. Signatures ran from Mar 1, 2023 to Apr 24, 2023.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-AZ | Raúl M. Grijalva | Mar 1, 2023 | |
| D-IL | Jonathan L. Jackson | Mar 9, 2023 | |
| D-MI | Shri Thanedar | Mar 9, 2023 | |
| D-TX | Al Green | Mar 10, 2023 | |
| D-DC | Eleanor Holmes Norton | Mar 21, 2023 | |
| D-WI | Gwen Moore | Mar 21, 2023 | |
| D-TX | Jasmine Crockett | Mar 21, 2023 | |
| D-IL | Jesús G. "Chuy" García | Mar 21, 2023 | |
| D-HI | Jill N. Tokuda | Mar 21, 2023 | |
| D-GA | Nikema Williams | Mar 21, 2023 | |
| D-TX | Sheila Jackson Lee | Mar 21, 2023 | |
| D-LA | Troy A. Carter | Mar 21, 2023 | |
| D-CA | Ted Lieu | Mar 22, 2023 | |
| D-CA | Jim Costa | Apr 3, 2023 | |
| D-CA | Barbara Lee | Apr 10, 2023 | |
| D-TX | Colin Z. Allred | Apr 10, 2023 | |
| D-AL | Terri A. Sewell | Apr 10, 2023 | |
| D-MD | Glenn Ivey | Apr 13, 2023 | |
| R-FL | Cory Mills | Apr 17, 2023 | |
| D-OH | Shontel M. Brown | Apr 17, 2023 | |
| D-TX | Vicente Gonzalez | Apr 24, 2023 |
Withdrew 2 Lloyd Doggett D-TX May 16, 2023·Danny K. Davis D-IL May 25, 2023
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Feb 9, 2023 |
| Health Subcommittee | Referred Feb 17, 2023 |
Actions 3
Everything that happened, newest first.
- Feb 17, 2023Referred to the Subcommittee on Health.
- Feb 9, 2023Introduced in House
- Feb 9, 2023Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 27, February 9, 2023, page H827.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R48483 | U.S. Food and Drug Administration (FDA) Regulation of Electronic Nicotine Delivery Systems (ENDS): Background and Selected Policy Issues | Report | Apr 4, 2025 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products.
- Short Title(s) as Introduced
- Disposable ENDS Product Enforcement Act of 2023
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Feb 9, 2023Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.